55400-94-7

Basic information

• Product Name: Benzaldehyde, 2-(3-butenyloxy)-
• CAS NO: 55400-94-7
• Molecular Formula: C11H12O2
• Molecular Weight: 176.215
• Mol File: 55400-94-7.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 287.9±23.0 °C(Predicted)
• Density: 1.038±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzaldehyde, 2-(3-butenyloxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2-(3-butenyloxy)-(55400-94-7)
• EPA Substance Registry System: Benzaldehyde, 2-(3-butenyloxy)-(55400-94-7)

Safety Data

• Hazardous Substances Data: 55400-94-7(Hazardous Substances Data)

Upstream product

• 778-29-0 but-3-enyl 4-methylbenzenesulfonate 
• 90-02-8 salicylaldehyde 
• 5162-44-7 1-bromo-4-butene 
• 89-95-2 2-methyl-benzyl alcohol 

Downstream Products

• 860782-33-8 (3R,4S)-1-benzoyl-3-O-triisopropylsilyloxy-4-(o-(but-3-enyloxy)phenyl)azetidin-2-one 
• 941672-18-0 4-(2-but-3-enyloxy-phenyl)-3-hydroxy-1-(4-methoxy-phenyl)-azetidin-2-one 
• 930785-89-0 4-(2-but-3-enyloxy-phenyl)-3-triisopropylsilanyloxy-azetidin-2-one 
• 930785-84-5 acetic acid 2-(2-but-3-enyloxy-phenyl)-1-(4-methoxy-phenyl)-4-oxo-azetidin-3-yl ester 
• 930785-87-8 4-(2-but-3-enyloxy-phenyl)-1-(4-methoxy-phenyl)-3-triisopropylsilanyloxy-azetidin-2-one 
• 956042-31-2 C₅₀H₅₃NO₁₅ 
• 860782-63-4 3'-dephenyl-3'-(o-[but-3-enyloxy]phenyl)-4-deacetyl-4-acryloyl-7-O-triethylsilyl-2'-O-triisopropylsilylpaclitaxel 
• 1449332-03-9 C₂₄H₂₄O₄S₂ 

Relevant articles and documents

MACROCYCLIC COMPOUNDS USEFUL AS CHITINASE INHIBITORS

The present invention relates to macrocyclic compounds of formula (I) and their use as chitinase inhibitors as well as to pharmaceutical compositions and methods of preparation thereof. The compounds can in particular be used in the treatment, prevention and/or amelioration of asthma.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection. Formule (I)

Rh-catalyzed intramolecular olefin hydroacylation: Enantioselective synthesis of seven- And eight-membered heterocycles

-